The role of endoscopist adenoma detection rate in in sex differences in colonoscopy findings: cross-sectional analysis of the SCREESCO randomized controlled trial

References

• Andersson KL, Ha JB, Abraczinskas DR, et al. Gender differences in colonoscopy: implications for clinical practice and female gastroenterologists. Dig Dis Sci. 2022;67(3):810–816. doi:10.1007/s10620-021-07079-y.
   PubMed Web of Science ®Google Scholar
• Bevan R, Blanks RG, Nickerson C, et al. Factors affecting adenoma detection rate in a national flexible sigmoidoscopy screening programme: a retrospective analysis. Lancet Gastroenterol Hepatol. 2019;4(3):239–247. doi:10.1016/S2468-1253(18)30387-X.
   PubMed Web of Science ®Google Scholar
• Sekiguchi M, Westerberg M, Ekbom A, et al. Detection rates of colorectal neoplasia during colonoscopies and their associated factors in the SCREESCO study. J Gastroenterol Hepatol. 2022;37(11):2120–2130. doi:10.1111/jgh.15990.
   PubMed Web of Science ®Google Scholar
• Singh S, Dhawan M, Chowdhry M, et al. Differences between morning and afternoon colonoscopies for adenoma detection in female and male patients. Ann Gastroenterol. 2016;29(4):497–501. doi:10.20524/aog.2016.0079.
   PubMedGoogle Scholar
• Gohel TD, Burke CA, Lankaala P, et al. Polypectomy rate: a surrogate for adenoma detection rate varies by Colon segment, gender, and endoscopist. Clin Gastroenterol Hepatol. 2014;12(7):1137–1142. doi:10.1016/j.cgh.2013.11.023.
   PubMed Web of Science ®Google Scholar
• James P, Hegagi M, Hegagi M, et al. Variable endoscopist performance in proximal and distal adenoma detection during colonoscopy: a retrospective cohort study. BMC Gastroenterol. 2018;18(1):73. doi:10.1186/s12876-018-0800-4.
   PubMedGoogle Scholar
• Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi:10.3322/caac.21492.
   PubMed Web of Science ®Google Scholar
• Cardoso R, Guo F, Heisser T, et al. Colorectal cancer incidence, mortality, and stage distribution in european countries in the colorectal cancer screening era: an international population-based study. Lancet Oncol. 2021;22(7):1002–1013. doi:10.1016/S1470-2045(21)00199-6.
   PubMed Web of Science ®Google Scholar
• Cassell BE, Ross K, Chang TY, et al. Predictors of failed conscious sedation in patients undergoing an outpatient colonoscopy and implications for the adenoma detection rate. Sci Rep. 2020;10(1):2167. doi:10.1038/s41598-020-59189-8.
   PubMed Web of Science ®Google Scholar
• Childers RE, Williams JL, Sonnenberg A. Practice patterns of sedation for colonoscopy. Gastrointest Endosc. 2015;82(3):503–511. doi:10.1016/j.gie.2015.01.041.
   PubMed Web of Science ®Google Scholar
• Bretthauer M, Kaminski MF, Løberg M, et al. Population-based colonoscopy screening for colorectal cancer: a randomized clinical trial. JAMA Intern Med. 2016;176(7):894–902. doi:10.1001/jamainternmed.2016.0960.
   PubMed Web of Science ®Google Scholar
• Sekiguchi M, Westerberg M, Ekbom A, et al. Endoscopist characteristics and polyp detection in colonoscopy: cross-sectional analyses of screening of Swedish colons. Gastroenterology. 2023;164(2):293–295 e4. doi:10.1053/j.gastro.2022.10.003.
   PubMed Web of Science ®Google Scholar
• Kaminski MF, Thomas-Gibson S, Bugajski M, et al. Performance measures for lower gastrointestinal endoscopy: a European Society of Gastrointestinal Endoscopy (ESGE) quality improvement initiative. Endoscopy. 2017;49(4):378–397. doi:10.1055/s-0043-103411.
   PubMed Web of Science ®Google Scholar
• Forsberg A, Westerberg M, Metcalfe C, et al. Once-only colonoscopy or two rounds of faecal immunochemical testing 2 years apart for colorectal cancer screening (SCREESCO): preliminary report of a randomised controlled trial. Lancet Gastroenterol Hepatol. 2022;7(6):513–521. doi:10.1016/S2468-1253(21)00473-8.
   PubMed Web of Science ®Google Scholar
• Strömberg U, Bonander C, Westerberg M, et al. Colorectal cancer screening with fecal immunochemical testing or primary colonoscopy: an analysis of health equity based on a randomised trial. EClinicalMedicine. 2022;47:101398. doi:10.1016/j.eclinm.2022.101398.
   PubMedGoogle Scholar
• Clark GR, Steele RJ, Fraser CG. Strategies to minimise the current disadvantages experienced by women in faecal immunochemical test-based colorectal cancer screening. Clin Chem Lab Med. 2022;60(10):1496–1505. doi:10.1515/cclm-2022-0583.
   PubMed Web of Science ®Google Scholar
• Ghanouni A, Plumb A, Hewitson P, et al. Patients’ experience of colonoscopy in the english bowel cancer screening programme. Endoscopy. 2016;48(3):232–240. doi:10.1055/s-0042-100613.
   PubMed Web of Science ®Google Scholar
• McLachlan SA, Clements A, Austoker J. Patients’ experiences and reported barriers to colonoscopy in the screening context–a systematic review of the literature. Patient Educ Couns. 2012;86(2):137–146. doi:10.1016/j.pec.2011.04.010.
   PubMed Web of Science ®Google Scholar
• Fritzell K, Forsberg A, Wangmar J, et al. Gender, having a positive FIT and type of hospital are important factors for colonoscopy experience in colorectal cancer screening - findings from the SCREESCO study. Scand J Gastroenterol. 2020;55(11):1354–1362. doi:10.1080/00365521.2020.1820568.
   PubMed Web of Science ®Google Scholar
• Mohan BP, Khan SR, Daugherty E, et al. Pooled rates of adenoma detection by colonoscopy in asymptomatic average-risk individuals with positive fecal immunochemical test: a systematic review and meta-analysis. Gastrointest Endosc. 2022;96(2):208–222 e14. doi:10.1016/j.gie.2022.04.004.
   PubMed Web of Science ®Google Scholar
• Shaukat A, Holub J, Pike IM, et al. Benchmarking adenoma detection rates for colonoscopy: results from a US-based registry. Am J Gastroenterol. 2021;116(9):1946–1949. doi:10.14309/ajg.0000000000001358.
   PubMed Web of Science ®Google Scholar
• Cavicchi M, Tharsis G, Burtin P, et al. Difference in physician-and patient-dependent factors contributing to adenoma detection rate and serrated polyp detection rate. Dig Dis Sci. 2019;64(12):3579–3588. doi:10.1007/s10620-019-05808-y.
   PubMed Web of Science ®Google Scholar
• Hassan C, Piovani D, Spadaccini M, et al. Variability in adenoma detection rate in control groups of randomized colonoscopy trials: a systematic review and meta-analysis. Gastrointest Endosc. 2023;97(2):212–225 e7. doi:10.1016/j.gie.2022.10.009.
   PubMed Web of Science ®Google Scholar
• Schottinger JE, Jensen CD, Ghai NR, et al. Association of physician adenoma detection rates with postcolonoscopy colorectal cancer. JAMA. 2022;327(21):2114–2122. doi:10.1001/jama.2022.6644.
   PubMed Web of Science ®Google Scholar
• Do A, Weinberg J, Kakkar A, et al. Reliability of adenoma detection rate is based on procedural volume. Gastrointest Endosc. 2013;77(3):376–380. doi:10.1016/j.gie.2012.10.023.
   PubMed Web of Science ®Google Scholar
• Sarvepalli S, Garber A, Rothberg MB, et al. Association of adenoma and proximal sessile serrated polyp detection rates with endoscopist characteristics. JAMA Surg. 2019;154(7):627–635. doi:10.1001/jamasurg.2019.0564.
   PubMed Web of Science ®Google Scholar
• Jover R, Zapater P, Bujanda L, et al. Endoscopist characteristics that influence the quality of colonoscopy. Endoscopy. 2016;48(3):241–247. doi:10.1055/s-0042-100185.
   PubMedGoogle Scholar
• Mehrotra A, Morris M, Gourevitch RA, et al. Physician characteristics associated with higher adenoma detection rate. Gastrointest Endosc. 2018;87(3):778–786. e5. doi:10.1016/j.gie.2017.08.023.
   PubMed Web of Science ®Google Scholar
• Samnani S, Khan R, Heitman SJ, et al. Optimizing adenoma detection in screening-related colonoscopy. Expert Rev Gastro­enterol Hepatol. 2023;17(6):589–602. doi:10.1080/17474124.2023.2212159.
   PubMed Web of Science ®Google Scholar